[1]
“АNTIPHOSPHOLIPID SYNDROME AS A CAUSATIVE FACTOR IN ENDOMETRIAL FAILURE”, Journal of Pharmaceutical Negative Results, pp. 6544–6549, Dec. 2022, doi: 10.47750/pnr.2022.13.S09.780.